NVO
NYSE HealthcareNovo Nordisk A/S Common Stock
Drug Manufacturers - General
📊 Market Data
| Price | $38.02 |
|---|---|
| Volume | 17,048,349 |
| Market Cap | 169.56B |
| Dividend Yield | 4.79% |
| Beta | 0.270 |
| RSI (14-Day) | 23.1 Oversold |
| 200-Day MA | $55.68 |
| 50-Day MA | $50.24 |
| 52-Week High | $82.57 |
| 52-Week Low | $35.85 |
| P/E Ratio | 10.62 |
| Forward P/E | 11.38 |
| Price / Book | 5.64 |
🎯 Investment Strategy Scores
How NVO scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
87/100
High dividend yield + low volatility
🚀 Moon Shot
31/100
High growth potential (high beta + oversold)
🔪 Falling Knife
94/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
18/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
97/100
Large-cap, institutional-quality stocks
Find NVO in your text
Paste any text on the homepage — the tool will extract NVO and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.